Impact Factor 2.635 | CiteScore 2.99
More on impact ›
The section is devoted to the publication of high quality research concerning all aspects of neuropharmacology; the study of drugs and their targets that influence the functions of the nervous system (brain, spinal cord, and peripheral nerves) in health and disease. The scope of the section is broad and submission of research from the cellular and molecular biology of drug targets through to their roles in isolated tissues and whole organisms, including clinical work, is welcome. Also relevant to the section is research (either pre-clinical or clinical) to elucidate basic neuropharmacological mechanisms in health and disease or the potential of a neuropharmacological strategy for therapeutic benefit.
Indexed in: PubMed, PubMed Central, Scopus, Google Scholar, DOAJ, CrossRef, EMBASE, Science Citation Index Expanded, CLOCKSS
PMCID: all published articles receive a PMCID
Neuropharmacology welcomes submissions of the following article types: Brief Research Report, Case Report, Clinical Trial, Community Case Study, Correction, Data Report, Editorial, General Commentary, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Review, Specialty Grand Challenge, Study Protocol, Systematic Review and Technology and Code.
All manuscripts must be submitted directly to the section Neuropharmacology, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Articles published in the section Neuropharmacology will benefit from the Frontiers impact and tiering system after online publication. Authors of published original research with the highest impact, as judged democratically by the readers, will be invited by the Chief Editor to write a Frontiers Focused Review - a tier-climbing article. This is referred to as "democratic tiering". The author selection is based on article impact analytics of original research published in all Frontiers specialty journals and sections. Focused Reviews are centered on the original discovery, place it into a broader context, and aim to address the wider community across all of Neuroscience, Neurology and Pharmacology.
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
For all queries regarding manuscripts in Review and potential conflicts of interest, please contact email@example.com
For queries regarding Research Topics, Editorial Board applications, and journal development, please contact firstname.lastname@example.org